Overview

A Study to Compare the Bioavailability and Pharmacokinetics of Cyclosporine After Intravenous Administration of NEUROSTAT®, a CREMOPHOR® EL-free Lipid Emulsion, and SANDIMMUNE® Injection (a Suspension of Cyclosporine in CREMOPHOR® EL) in Healthy

Status:
Completed
Trial end date:
2010-01-01
Target enrollment:
Participant gender:
Summary
To compare the bioavailability, pharmacokinetic profiles and the tolerability of two formulations of intravenous cyclosporine in healthy volunteers.
Phase:
Phase 1
Details
Lead Sponsor:
NeuroVive Pharmaceutical AB
Treatments:
Cyclosporine
Cyclosporins
Glycerol